Nasal congestion and drugs of ingredients of guanfacine hydrochloride - a phase IV clinical study of FDA data

---

---

Number of reports submitted per year:

Time on drugs with ingredients of guanfacine hydrochloride when people have Nasal congestion *:

• < 1 month: 100 %
• 1 - 6 months: 0.0 %
• 6 - 12 months: 0.0 %
• 1 - 2 years: 0.0 %
• 2 - 5 years: 0.0 %
• 5 - 10 years: 0.0 %
• 10+ years: 0.0 %

Gender of people who have Nasal congestion when taking drugs with ingredients of guanfacine hydrochloride *:

• female: 18.18 %
• male: 81.82 %

Age of people who have Nasal congestion when taking drugs with ingredients of guanfacine hydrochloride *:

• 0-1: 0.0 %
• 2-9: 3.7 %
• 10-19: 77.78 %
• 20-29: 0.0 %
• 30-39: 3.7 %
• 40-49: 3.7 %
• 50-59: 0.0 %
• 60+: 11.11 %

Conditions people have *:

1. Asthma: 22 people, 61.11%
2. Depression: 2 people, 5.56%
3. Irritability: 2 people, 5.56%
4. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 2.78%
5. Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 2.78%
6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 2.78%
7. Cough: 1 person, 2.78%
8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 2.78%
9. Eye Disorder: 1 person, 2.78%
10. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 2.78%

Other drugs people take *:

1. Prozac: 24 people, 66.67%
2. Xolair: 20 people, 55.56%
3. Fluoxetine: 16 people, 44.44%
4. Seroquel: 10 people, 27.78%
5. Cardura: 3 people, 8.33%
6. Singulair: 3 people, 8.33%
7. Claritin: 3 people, 8.33%
8. Klor-Con: 2 people, 5.56%
9. Letairis: 2 people, 5.56%
10. Concerta: 2 people, 5.56%

Other side effects people have besides Nasal congestion *:

1. Hypotension (abnormally low blood pressure): 22 people, 61.11%
2. Oropharyngeal Pain: 20 people, 55.56%
3. Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 20 people, 55.56%
4. Cough: 20 people, 55.56%
5. Forced Expiratory Volume Decreased (decreased lung expired air volume): 20 people, 55.56%
6. Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 19 people, 52.78%
7. Heart Rate Irregular: 19 people, 52.78%
8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 19 people, 52.78%
9. Lower Respiratory Tract Infection: 18 people, 50.00%
10. Malaise (a feeling of general discomfort or uneasiness): 18 people, 50.00%

---